van Vugt MA - Search Results

1

Targeting of β1 integrins impairs DNA repair for radiosensitization of head and neck cancer cells.

Dickreuter E, Eke I, Krause M, Borgmann K, van Vugt MA, Cordes N. Dickreuter E, et al. Among authors: van vugt ma. Oncogene. 2016 Mar 17;35(11):1353-62. doi: 10.1038/onc.2015.212. Epub 2015 Jun 15. Oncogene. 2016. PMID: 26073085

2

Forced activation of Cdk1 via wee1 inhibition impairs homologous recombination.

Krajewska M, Heijink AM, Bisselink YJ, Seinstra RI, Silljé HH, de Vries EG, van Vugt MA. Krajewska M, et al. Among authors: van vugt ma. Oncogene. 2013 Jun 13;32(24):3001-8. doi: 10.1038/onc.2012.296. Epub 2012 Jul 16. Oncogene. 2013. PMID: 22797065

3

ATR inhibition preferentially targets homologous recombination-deficient tumor cells.

Krajewska M, Fehrmann RS, Schoonen PM, Labib S, de Vries EG, Franke L, van Vugt MA. Krajewska M, et al. Among authors: van vugt ma. Oncogene. 2015 Jun;34(26):3474-81. doi: 10.1038/onc.2014.276. Epub 2014 Sep 1. Oncogene. 2015. PMID: 25174396

4

Therapeutic targeting and patient selection for cancers with homologous recombination defects.

Talens F, Jalving M, Gietema JA, Van Vugt MA. Talens F, et al. Among authors: van vugt ma. Expert Opin Drug Discov. 2017 Jun;12(6):565-581. doi: 10.1080/17460441.2017.1322061. Epub 2017 May 2. Expert Opin Drug Discov. 2017. PMID: 28425306 Free article. Review.

5

TPX2/Aurora kinase A signaling as a potential therapeutic target in genomically unstable cancer cells.

van Gijn SE, Wierenga E, van den Tempel N, Kok YP, Heijink AM, Spierings DCJ, Foijer F, van Vugt MATM, Fehrmann RSN. van Gijn SE, et al. Oncogene. 2019 Feb;38(6):852-867. doi: 10.1038/s41388-018-0470-2. Epub 2018 Sep 3. Oncogene. 2019. PMID: 30177840 Free PMC article.

6

Getting in and out of mitosis with Polo-like kinase-1.

van Vugt MA, Medema RH. van Vugt MA, et al. Oncogene. 2005 Apr 18;24(17):2844-59. doi: 10.1038/sj.onc.1208617. Oncogene. 2005. PMID: 15838519 Review.

7

The role of ATM and 53BP1 as predictive markers in cervical cancer.

Roossink F, Wieringa HW, Noordhuis MG, ten Hoor KA, Kok M, Slagter-Menkema L, Hollema H, de Bock GH, Pras E, de Vries EG, de Jong S, van der Zee AG, Schuuring E, Wisman GB, van Vugt MA. Roossink F, et al. Among authors: van vugt ma, van der zee ag. Int J Cancer. 2012 Nov 1;131(9):2056-66. doi: 10.1002/ijc.27488. Epub 2012 Mar 29. Int J Cancer. 2012. PMID: 22323184 Free PMC article.

8

The DNA damage response during mitosis.

Heijink AM, Krajewska M, van Vugt MA. Heijink AM, et al. Among authors: van vugt ma. Mutat Res. 2013 Oct;750(1-2):45-55. doi: 10.1016/j.mrfmmm.2013.07.003. Epub 2013 Jul 21. Mutat Res. 2013. PMID: 23880065 Review.

9

Plk1 Manages DNA break repair during mitosis.

Alves IT, van Vugt MA. Alves IT, et al. Among authors: van vugt ma. Cell Cycle. 2015;14(9):1356-7. doi: 10.1080/15384101.2015.1024586. Cell Cycle. 2015. PMID: 25789670 Free PMC article. No abstract available.

10

Regulators of homologous recombination repair as novel targets for cancer treatment.

Krajewska M, Fehrmann RS, de Vries EG, van Vugt MA. Krajewska M, et al. Among authors: van vugt ma. Front Genet. 2015 Mar 20;6:96. doi: 10.3389/fgene.2015.00096. eCollection 2015. Front Genet. 2015. PMID: 25852742 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

102 results

Search Page